Cogent Biosciences Cash Flow Statement (2017-2026) | COGT

Cash Flow Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-17.17M-19.70M-25.53M-31.31M-35.58M-35.32M-41.63M-40.97M-44.34M-55.38M-54.36M-58.35M-58.99M-70.64M-69.88M-71.98M-73.52M-80.93M-95.31M-97.21M
Share-based Compensation (Quarter)
2.59M3.46M3.85M4.17M4.53M4.62M5.04M5.85M7.16M8.76M8.85M9.39M10.01M10.36M9.98M10.01M9.72M10.60M1.10M16.91M
Gains from Sales and Divestitures (Quarter)
0.08M
Gains from Investment Securities (Quarter)
0.73M3.40M3.40M0.92M1.11M0.73M-24.18M0.49M0.44M15.50M-0.28M2.73M0.58M2.71M1.43M1.61M0.30M0.34M1.15M
Non-cash Items (Quarter)
43.70M42.60M1.35M54.60M51.60M49.00M47.50M0.30M0.30M55.00M8.44M55.60M12.40M10.80M0.20M8.30M6.20M3.30M16.78M44.60M
Cash from Operations (Quarter)
-12.51M-14.11M-20.78M-28.33M-26.46M-34.44M-29.41M-39.52M-32.07M-37.97M-44.07M-52.53M-42.70M-51.98M-60.58M-66.51M-54.54M-64.29M-79.11M-86.88M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.47M0.48M0.49M0.57M-0.61M1.18M0.19M0.65M0.27M0.20M0.47M-1.65M6.20M-3.11M0.50M0.50M0.51M0.46M1.18M
Amortization of Deferred Charges (Quarter)
0.06M0.30M0.24M0.28M
Depreciation & Amortization (CF) (Quarter)
0.01M0.05M0.07M0.07M0.10M0.26M0.38M0.53M0.56M0.58M0.63M0.60M0.61M0.62M0.68M0.64M0.66M0.64M0.66M0.63M
Change in Working Capital
Change in Receivables (Quarter)
Change in Account Payables (Quarter)
1.68M2.36M-0.87M0.53M-0.52M0.60M1.75M-1.67M2.99M2.71M0.79M4.91M-6.59M6.09M-3.05M2.14M2.47M-0.60M-6.53M4.24M
Change in Accured Expenses (Quarter)
3.69M0.60M1.16M0.20M2.97M2.61M3.81M-2.56M1.85M6.25M2.63M-6.72M10.10M6.92M-10.29M0.01M-2.98M4.57M9.10M0.03M
Other Working Capital Changes (Quarter)
3.36M0.07M-4.09M0.74M0.17M2.21M-11.81M-0.19M0.22M2.45M-1.85M0.00M1.69M-1.69M4.33M-2.17M-0.06M-0.81M3.24M-0.42M
Investing Activities
Capital Expenditures (Quarter)
1.16M0.43M0.44M1.14M3.31M1.97M1.10M1.26M0.12M0.32M0.07M0.15M0.28M0.07M0.55M0.13M0.07M0.81M0.45M
Change in Acquisitions & Divestments (Quarter)
120.00M50.00M22.06M61.72M74.13M65.92M79.93M74.47M69.93M76.92M69.08M73.26M97.83M
Cash from Investing Activities (Quarter)
-1.16M-0.43M-0.44M-1.14M-151.54M28.41M59.88M-77.66M-90.54M10.49M1.04M-84.62M60.19M61.67M69.38M8.91M-155.05M-322.77M-36.46M
Financing Activities
Other financing activities (Quarter)
10.80M10.70M11.60M0.70M1.37M0.23M46.59M
Cash from Financing Activities (Quarter)
0.06M38.01M0.14M162.12M0.99M0.32M0.45M162.09M1.00M214.06M-0.26M0.62M0.03M24.97M47.23M217.37M588.67M52.54M
Additional items
Change in Cash (Quarter)
-12.63M-15.22M16.80M-28.64M134.51M-184.99M-0.68M20.81M52.36M-127.51M-33.58M162.57M-127.58M8.83M1.12M27.84M1.59M-1.97M186.79M-70.80M
Free Cash Flow (Quarter)
-12.51M-15.27M-21.21M-28.77M-27.60M-37.75M-31.38M-40.62M-33.32M-38.09M-44.38M-52.60M-42.85M-52.26M-60.65M-67.06M-54.67M-64.35M-79.92M-87.33M
Net Cash Flow (Quarter)
-12.51M-15.22M16.80M-28.64M134.51M-184.99M-0.68M20.81M52.36M-127.51M-33.58M162.57M-127.58M8.83M1.12M27.84M1.59M-1.97M186.79M-70.80M